Lymphangiogenesis: in vitro and in vivo models

被引:70
|
作者
Bruyere, Francoise [1 ]
Noel, Agnes [1 ]
机构
[1] Univ Liege, Lab Tumor & Dev Biol, GIGA Canc, CHU Sart Tilman B23, B-4000 Liege, Belgium
来源
FASEB JOURNAL | 2010年 / 24卷 / 01期
关键词
lymphatic endothelial cell; lymphedema; metastatic dissemination; graft rejection; LYMPHATIC ENDOTHELIAL-CELLS; GROWTH-FACTOR-C; VEGF-C; NODE METASTASIS; INTERSTITIAL FLOW; TUMOR LYMPHANGIOGENESIS; FACTOR RECEPTOR-3; THORACIC-DUCT; GENE-THERAPY; INTRATUMORAL LYMPHANGIOGENESIS;
D O I
10.1096/fj.09-132852
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Lymphangiogenesis, the formation of new lymphatic vessels from preexisting ones, is an important biological process associated with diverse pathologies, such as metastatic dissemination and graft rejection. In addition, lymphatic hypoplasia characterizes lymphedema, usually a progressive and lifelong condition for which no curative treatment exists. Much progress has been made in recent years in identifying molecules specifically expressed on lymphatic vessels and in the setting up of in vitro and in vivo models of lymphangiogenesis. These new tools rapidly provided an abundance of information on the mechanisms underlying lymphatic development and the progression of diseases associated with lymphatic dysfunction. In this review, we describe the common in vitro and in vivo models of lymphangiogenesis that have proven suitable for investigating lymphatic biology and the interactions occurring between lymphatic vessels and other cells, such as immune cells and cancer cells. Their rationales and limitations are discussed and illustrated by the most informative findings obtained with them.-Bruyere, F., Noel, A. Lymphangiogenesis: in vitro and in vivo models. FASEB J. 24, 8 - 21 (2010). www.fasebj.org
引用
收藏
页码:8 / 21
页数:14
相关论文
共 50 条
  • [1] In Vitro, In Vivo, and In Silico Models of Lymphangiogenesis in Solid Malignancies
    Bekisz, Sophie
    Baudin, Louis
    Buntinx, Florence
    Noel, Agnes
    Geris, Liesbet
    CANCERS, 2022, 14 (06)
  • [2] In Vivo Angiogenesis and Lymphangiogenesis Models
    Jensen, L. D.
    Cao, R.
    Cao, Y.
    CURRENT MOLECULAR MEDICINE, 2009, 9 (08) : 982 - 991
  • [3] Curcumin inhibits lymphangiogenesis in vitro and in vivo
    Wang, Weicang
    Sukamtoh, Elvira
    Xiao, Hang
    Zhang, Guodong
    MOLECULAR NUTRITION & FOOD RESEARCH, 2015, 59 (12) : 2345 - 2354
  • [4] Allicin Inhibits Lymphangiogenesis in vitro and in vivo
    Wang, Weicang
    FASEB JOURNAL, 2016, 30
  • [5] Modeling lymphangiogenesis: Pairing in vitro and in vivo metrics
    Suarez, Aileen C.
    Hammel, Jennifer H.
    Munson, Jennifer M.
    MICROCIRCULATION, 2023, 30 (2-3)
  • [6] Inhibition of lymphangiogenesis in vitro and in vivo by the multikinase inhibitor nintedanib
    Lin, Tong
    Gong, Lan
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2017, 11 : 1147 - 1158
  • [7] Src Tyrosine Kinase Inhibition Suppresses Lymphangiogenesis In Vitro and In Vivo
    Ischenko, I.
    Seeliger, H.
    Camaj, P.
    Kleespies, A.
    Guba, M.
    Eichhorn, M. E.
    Jauch, K. -W.
    Bruns, C. J.
    CURRENT CANCER DRUG TARGETS, 2010, 10 (05) : 546 - 553
  • [8] Lymphangiogenesis in vitro
    Breier, G
    BLOOD, 2006, 107 (03) : 853 - 854
  • [9] Deletion of Tetraspanin CD9 Diminishes Lymphangiogenesis in Vivo and in Vitro
    Iwasaki, Takeo
    Takeda, Yoshito
    Maruyama, Kazuichi
    Yokosaki, Yasuyuki
    Tsujino, Kazuyuki
    Tetsumoto, Satoshi
    Kuhara, Hanako
    Nakanishi, Kaori
    Otani, Yasushi
    Jin, Yingji
    Kohmo, Satoshi
    Hirata, Haruhiko
    Takahashi, Ryo
    Suzuki, Mayumi
    Inoue, Koji
    Nagatomo, Izumi
    Goya, Sho
    Kijima, Takashi
    Kumagai, Toru
    Tachibana, Isao
    Kawase, Ichiro
    Kumanogoh, Atsushi
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2013, 288 (04) : 2118 - 2131
  • [10] In vivo model of lymphangiogenesis
    Boardman Jr., Kendrick
    Swartz, Melody
    Annals of Biomedical Engineering, 2000, 28 (SUPPL. 1)